Navigation Links
John McEnroe is Serious About Getting Men to Take the '50 Over 50 Prostate Health Challenge'
Date:3/16/2009

PHILADELPHIA, March 16 /PRNewswire/ -- Three-time Wimbledon and four-time US Open Champion John McEnroe has teamed up with GlaxoSmithKline (NYSE: GSK) to create a public-education initiative entitled the "50 Over 50 Prostate Health Challenge."

Fifty percent of men over 50 years of age have an enlarging prostate; if left untreated it can lead to worsening urinary symptoms and even prostate-related surgery.

"I just celebrated my 50th birthday, and while I'm still as active as ever, I know there are certain health issues I need to stay on top of, including my prostate health," said McEnroe. "Now I'm asking other men to take the '50 Over 50 Prostate Health Challenge.' It's all about talking to your doctor and getting serious about your prostate health."

As a part of the campaign, an interactive web site, www.50over50challenge.com, has been created where men can start the "Prostate Health Challenge." The challenge is to take three easy steps to get serious about prostate health: a brief online prostate health assessment; seeing a doctor for a prostate-health exam; and knowing your PSA (Prostate-specific antigen) level. PSA level, obtained from a simple blood test, is a protein marker that can rise when a prostate condition is present.

McEnroe will also be featured in public education video messages that will appear throughout the year on network television, internet sites and at 50over50challenge.com. The first video vignette will air on April 4 in between the first and second games of the men's college basketball semi final on CBS. There will also be national print messages in March and April running in such publications as USA Today, Sports Illustrated, Time and Newsweek.

"Prostate health can be awkward to talk about, so we've created a series of hopefully memorable, vignettes to help get men talking. I am hoping my involvement will be motivational and encourage men to take the Challenge and take control of their prostate health," added McEnroe.

About Enlarging Prostate

Enlarging prostate is a prevalent and progressive condition that affects approximately 50 percent of men over 50 years of age and over 90 percent of men older than age 80. An enlarged prostate can cause changes in urinary habits because of its location around the urethra. Over time, the prostate can continue to grow and urinary symptoms may worsen as the bladder loses the ability to empty itself. Left untreated, in severe cases, an enlarged prostate can lead to serious long-term problems including acute urinary retention (AUR) and the need for prostate-related surgery.

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Superstar John McEnroe to Highlight The Kennedy Funding Invitational Tennis Tournament, July 9-13, 2008
2. Local Communities Get Serious About Saving Lives Through Project Lifesaver Tracking Equipment, Says NAA
3. New Texas Study Reveals Serious Flaws in Abstinence Programs
4. Harmonix Music Systems, Inc. and MTV Games Make a Donation to Starlight and Bring Rock Band(R) to Thousands of Seriously Ill Children
5. IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
6. Sexual health promotion is low among people with serious mental illnesses, despite higher risk
7. Pharmaceuticals sold in Sweden cause serious environmental harm in India
8. Physical activity, mood and serious mental illness
9. AFB Survey Finds Drug Labeling Puts People with Vision Loss at Serious Medical Risk
10. Late preterm births present serious risks to newborns
11. Americans Want Schools to Take Recess Seriously
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... ... February 22, 2017 , ... The National Academy of Certified ... the April 2017 testing period. NACCM, a nonprofit organization, has provided the premier ... exam is periodically re-calibrated to ensure that newly certified professionals are prepared to ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... understand each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as ... helps transform the HCC Risk Adjustment process from a typical fragmented process ...
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its steady ... Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission Hills ... liability and other personal injury cases. These injuries have a major impact on ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... Using the ... leads utilizing a simple online checklist. Over a period of just 24 months, thousands ... assistance of an online checklist called T.A.D. , “The internet is not getting quieter. ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for ... help small practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for ... and CHIP Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , February 23, 2017 ... market: the Berlin office was ... Magdalena Kritikos . The portfolio includes Entocort ® ... for the treatment of ulcerative colitis, and VistaPrep ® ... solutions, the Swiss specialty pharmaceutical company focused on the ...
(Date:2/23/2017)... 2017 MabVax Therapeutics Holdings, Inc ... company, announces that it has received notice from ... the initiation a Phase I clinical trial with ... MVT-1075 ( 177 Lu-CHX-A?-DTPA-HuMab5B1) is the Company,s novel ... initiate the phase I clinical trial in patients ...
(Date:2/23/2017)... 23, 2017 Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ... oncology and dermatology biopharmaceutical company, today announced that it ... Rodrigues as special advisers to the Company,s Board ... the board on financial and corporate strategy. ... commitment of up to $2.5 million from Eric ...
Breaking Medicine Technology: